Large Real-World study tracks olaparib side effects in chinese patients
NCT ID NCT04560452
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study observed over 1,000 Chinese patients with ovarian or prostate cancer who were already taking or starting the drug olaparib. Researchers tracked side effects and how doctors managed them in everyday practice. The goal was to better understand the drug's safety in this specific population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Anhui, China
-
Research Site
Beijing, China
-
Research Site
Changsha, China
-
Research Site
Chengdu, China
-
Research Site
Chongqing, China
-
Research Site
Dongguan, China
-
Research Site
Foshan, China
-
Research Site
Fujian, China
-
Research Site
Guangdong, China
-
Research Site
Guangzhou, China
-
Research Site
Guangzho, China
-
Research Site
Guizhou, China
-
Research Site
Hangzhou, China
-
Research Site
He'nan, China
-
Research Site
Hebei, China
-
Research Site
Heilongjiang, China
-
Research Site
Henan, China
-
Research Site
Huizhou, China
-
Research Site
Jiangsu, China
-
Research Site
Jiangxi, China
-
Research Site
Jilin City, China
-
Research Site
Jinghou, China
-
Research Site
Liaoning, China
-
Research Site
Luzhou, China
-
Research Site
Nanjing, China
-
Research Site
Nantong, China
-
Research Site
Ningbo, China
-
Research Site
Shandong, China
-
Research Site
Shanghai, China
-
Research Site
Shenyang, China
-
Research Site
Sichuan, China
-
Research Site
Taiyuan, China
-
Research Site
Tianjin, China
-
Research Site
Yichang, China
-
Research Site
Yunan, China
-
Research Site
Zhejiang, China
-
Research Site
Zhengzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks